Skip to main content
. 2021 Sep 9;16(9):e0257132. doi: 10.1371/journal.pone.0257132

Fig 3. Kaplan-Meier survival curves of kidney cancer patients with any CHEK2 mutation and -negative sub-cohorts.

Fig 3